艾吉納斯 AGEN 深 滬
等待開盤 07-22 09:30:00 美东时间
5.58
+0.610
+12.27%
華盛通- 最 高5.90
- 今 開5.00
- 成交量 259.19万股
- 最 低 4.99
- 昨 收 4.97
- 總市值 2.32亿
- 52周最高 8.70
- 市盈率 靜 --
- 換手率 6.22%
- 52周最低 2.71
- 委 比 -21.73%
- 總股本 4164.24万
- 歷史最高 202.5868
- 量 比 0.59
- 振 幅 18.31%
- 歷史最低 1.38
- 每 手 1
- 風險率 0.74%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Top 3 Penny Stocks to Watch after Massive Trading Volume, 7/14/2026
Twin Vee PowerCats, Agenus, and SOBR Safe are among the toppenny stocks&n...
07-14 22:35
美股牛股 | Q32 Bio飙升90%，核心药物斑秃临床试验数据积极；Figma升12%
Q32 Bio飙升90%，核心药物斑秃临床试验数据积极；Braiin劲升16%，发布AI房地产平台；Figma升12%，Q2绩前获美银花旗双双看多>>
07-14 15:59
美股大行评级 | 花旗上调苹果、西部数据、希捷科技、超微电脑等目标价；高盛上调蔚来"买入"评级，目标价7美元
今日重点评级关注：HC Wainwright & Co.：维持艾吉纳斯"买入"评级，目标价从23美元升至30美元；富国银行：上调Q32 Bio评级至"超配"，目标价66美元
07-14 11:36
Why Is Agenus (AGEN) Stock Up Today?
Agenus stock was up on Monday alongside a new funding announcement and a price ...
07-14 00:51
HC Wainwright & Co. Maintains Buy on Agenus, Raises Price Target to $30
HC Wainwright & Co. analyst Emily Bodnar maintains Agenus (NASDAQ:AGEN) with a Buy and raises the price target from $23 to $30.
07-14 00:32
Why Is Agenus Stock Gaining Monday?
Agenus Inc. (NASDAQ:AGEN) reported updated three-year Phase 1b data showing durable survival with its botensilimab plus balstilimab combination in patients with refractory microsatellite-stable metastatic colorectal cancer without active liver metastases. Separately, the biotechnology company announ...
07-13 23:29
美股异动 | 将筹集最多3.4亿美元用于资助结肠癌药物试验 艾吉纳斯(AGEN.US)暴涨超130%
周一，艾吉纳斯(AGEN.US)早盘暴涨超130%，创两年新高，现报7.63美元。
07-13 22:54
Agenus Secures Strategic Financing to Advance Colon Cancer Program
The latest announcement is out from Agenus ( ($AGEN) ). On July 13, 2026, Agenu...
07-13 19:57
Market-Moving News for July 13th
QTTB: 82% | Q32 Bio shares are trading higher after the company it will report 36-week topline results from Part B of the SIGNAL-AA Phase 2a clinical trial on Monday, July 13, 2026. AGEN: 36% | Agenus To Raise $85M To Fund Colon Cancer Drug Trial, Financing Could Reach $340M If Warrants Are Exerci...
07-13 19:14
Agenus prices USD 85 million private placement, adds warrants for up to USD 340 million total proceeds
Agenus prices USD 85 million private placement, adds warrants for up to USD 340 million total proceeds Agenus priced an oversubscribed private placement targeting USD 85 million upfront gross proceeds, with up to USD 255 million more from warrant exercises. Deal includes 23,035,227 common shares or
07-13 18:34
